Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewCHDI 113 is a potent huntingtin (HTT) pre-mRNA splicing modulator (EC50 = 66 nM). It lowers HTT protein in both human Huntington's disease (HD) stem cells and in the brain of BACHD (bacterial artificial chromosome-mediated transgenic) mouse model. CHDI 113 is brain penetrant and orally bioavailable.
Sold under license from CHDI Foundation
M. Wt | 395.44 |
Formula | C20H22FN7O |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 2743336-70-9 |
PubChem ID | 166508076 |
InChI Key | VPWHAEPYJSEFEH-CQSZACIVSA-N |
Smiles | FC1=CC(NC(C2=NC=C(N3C[C@@H](CC3)NC4CC4)N=C2)=O)=CN5C1=NC(C)=C5 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 39.54 | 100 |
The following data is based on the product molecular weight 395.44. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.53 mL | 12.64 mL | 25.29 mL |
5 mM | 0.51 mL | 2.53 mL | 5.06 mL |
10 mM | 0.25 mL | 1.26 mL | 2.53 mL |
50 mM | 0.05 mL | 0.25 mL | 0.51 mL |
References are publications that support the biological activity of the product.
Liu et al (2023) Identification and optimization of RNA-splicing modulators as Huntingtin protein-lowering agents for the treatment of Huntington's disease. J.Med.Chem. 66 13205 PMID: 37712656
If you know of a relevant reference for CHDI 113, please let us know.
Keywords: CHDI 113, CHDI 113 supplier, CHDI113, Pre-mRNA, splicing, modulator, modulates, brain, penetrant, orally, bioavailable, huntingtons, disease, DNA, RNA, and, Protein, Synthesis, in, vivo, stem, cells, DNA,, Biochemicals, Molecular, Biology, 8063, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for CHDI 113 include:
Liu et al (2024) Identification and optimization of RNA-splicing modulators as Huntingtin protein-lowering agents for the treatment of Huntington's disease. J.Med.Chem. 66 13205 PMID: 37712656
Do you know of a great paper that uses CHDI 113 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review CHDI 113 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of: